SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-014686
Filing Date
2018-03-14
Accepted
2018-03-14 17:01:31
Documents
87
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv486897_10k.htm 10-K 1121458
2 EXHIBIT 21 tv486897_ex21.htm EX-21 2606
3 EXHIBIT 23.1 tv486897_ex23-1.htm EX-23.1 8345
4 EXHIBIT 31.1 tv486897_ex31-1.htm EX-31.1 8335
5 EXHIBIT 31.2 tv486897_ex31-2.htm EX-31.2 8244
6 EXHIBIT 32.1 tv486897_ex32-1.htm EX-32.1 3927
13 GRAPHIC tv486897_img1.jpg GRAPHIC 70065
  Complete submission text file 0001144204-18-014686.txt   6538355

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvax-20171231.xml EX-101.INS 1362779
8 XBRL TAXONOMY EXTENSION SCHEMA nvax-20171231.xsd EX-101.SCH 53567
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20171231_cal.xml EX-101.CAL 57605
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20171231_def.xml EX-101.DEF 365983
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20171231_lab.xml EX-101.LAB 466686
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20171231_pre.xml EX-101.PRE 428697
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 18690130
SIC: 2836 Biological Products, (No Diagnostic Substances)